Back to Stakeholders
Categories

1 domain / 2 areas / 1 specialization

Braeburn Inc.

Data updated

Biopharmaceutical company responsible for BRIXADI REMS implementation in the U.S., with certified provider and pharmacy requirements and controlled outpatient distribution pathways.

Regulation & Enforcement Snapshot

REMS Administrators

Authority Type

REMS Program Administrator

Jurisdiction

National

Coverage

1 country

Binding Strength

Programmatic Requirement

Function Areas

Risk Evaluation and Mitigation OversightData Reporting RequirementsCompliance Monitoring and Inspections

Framework / Program

BRIXADI REMS Program

Policy Notes

BRIXADI is distributed under a REMS framework with healthcare setting, prescriber, and pharmacy controls to reduce diversion and unsafe administration pathways.

Verification

Verified

Psychedelic Engagement

Psychedelic-Adjacent Focus

Framework Status

Active

Last Verified

Apr 8, 2026

Primary Policy Link

Quick Facts

Website
Visit